Skip to main content
    T

    Tvardi Therapeutics, Inc. (TVRD)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $1.07
    +0.07 (+7.00%)

    Market Cap: $13.34M

    Last updated: Oct 16, 2026 at 1:55 PM ET

    Earnings

    Performance (10Y)

    Beat Rate
    64%(21/33)
    Avg Surprise
    -175.46%

    Upcoming Estimates

    Period ending Sep 30, 2026
    EPS Consensus$-0.57
    Range$-1.06 - $-0.28
    8 analysts
    EPS Revisions
    1
    0
    7d
    2
    0
    30d
    EPS Estimate DriftChange to current
    90d ago$-0.54-6.4%
    60d ago$-0.53-8.7%
    30d ago$-0.59+2.6%
    7d ago$-0.570.0%
    Current$-0.57
    Revenue Consensus
    $0
    Range$0 - $0
    8 analysts
    Period ending Dec 31, 2026
    EPS Consensus$-0.38
    Range$-1.10 - $0.32
    8 analysts
    Revenue Consensus
    $0
    Range$0 - $0
    8 analysts
    PeriodReportedEst.SurpriseB/MYoY
    Dec 26EST
    		-$-0.38---
    Sep 26EST
    		-$-0.57---
    Jun 26
    Reported Aug 13
    		$-0.69$-0.65-6.15%Miss-235.3%
    Mar 26
    Reported May 8
    		$-0.73$-0.65-12.31%Miss-46.0%
    Dec 25
    Reported Mar 31
    		$-0.78$-0.57-36.84%Miss+85.0%
    Sep 25
    Reported Nov 13
    		$-0.59$-0.81+27.16%Beat+92.8%
    Jun 25
    Reported Aug 14
    		$0.51$-0.39+230.77%Beat+288.9%
    Mar 25
    Reported May 13
    		$-0.50$-0.58+13.79%Beat+10.7%
    Dec 24
    Reported Feb 26
    		$-5.21$-0.20-2548.70%Miss-783.1%
    Sep 24
    Reported Nov 29
    		$-8.19$-0.24-3312.25%Miss-1474.9%
    Jun 24
    Reported Aug 5
    		$-0.27$-0.26-3.85%Miss+53.4%
    Mar 24
    Reported May 13
    		$-0.56$-0.40-40.00%Miss-14.3%
    Dec 23
    Reported Mar 4
    		$-0.59$-0.45-31.11%Miss-5.4%
    Sep 23
    Reported Nov 13
    		$-0.52$-0.52+0.00%Beat-20.9%
    Jun 23
    Reported Aug 7
    		$-0.58$-0.54-7.41%Miss-625.0%
    Mar 23
    Reported May 15
    		$-0.49$-0.51+3.92%Beat+5.8%
    Dec 22
    Reported Mar 6
    		$-0.56$-0.32-75.00%Miss+11.1%
    Sep 22
    Reported Nov 7
    		$-0.43$-0.43+0.00%Beat-2050.0%
    Jun 22
    Reported Aug 8
    		$-0.08$-0.08+0.00%Beat+86.9%
    Mar 22
    Reported May 9
    		$-0.52$-0.52+0.00%Beat-10.6%
    Dec 21
    Reported Mar 1
    		$-0.63$-0.63+0.00%Beat-139.6%
    Sep 21
    Reported Nov 8
    		$-0.02$-0.02+0.00%Beat+94.3%
    Jun 21
    Reported Aug 9
    		$-0.61$-0.61+0.00%Beat-13.0%
    Mar 21
    Reported May 10
    		$-0.47$-0.47+0.00%Beat+24.2%
    Dec 20
    Reported Feb 25
    		$1.59$1.59+0.00%Beat+360.7%
    Sep 20
    Reported Nov 9
    		$-0.35$-0.35+0.00%Beat+52.7%
    Jun 20
    Reported Aug 10
    		$-0.54$-0.54+0.00%Beat+6.9%
    Mar 20
    Reported May 11
    		$-0.62$-0.62+0.00%Beat-10.7%
    Dec 19
    Reported Feb 27
    		$-0.61$-0.61+0.00%Beat-17.3%
    Sep 19
    Reported Nov 5
    		$-0.74$-0.74+0.00%Beat-45.1%
    Jun 19
    Reported Aug 7
    		$-0.58$-0.58+0.00%Beat-11.5%
    Mar 19
    Reported May 7
    		$-0.56$-0.58+3.45%Beat+97.0%
    Dec 18
    Reported Mar 12
    		$-0.52$-0.58+10.34%Beat+96.7%
    Sep 18
    Reported Nov 6
    		$-0.51$-0.49-4.08%Miss+96.3%
    Jun 18
    Reported Aug 7
    		$-0.52$-0.51-1.96%Miss+95.0%
    Mar 18
    Reported May 10
    		$-18.47N/AN/ABeat+36.9%
    Dec 17
    Reported Mar 16
    		$-15.64N/AN/ABeat+46.0%
    Sep 17
    Reported Nov 3
    		$-13.75N/AN/ABeat-
    Jun 17
    Reported Aug 4
    		$-10.38N/AN/ABeat-
    Mar 17
    Reported May 5
    		$-29.28N/AN/ABeat-
    Dec 16
    Reported Mar 10
    		$-28.98N/AN/ABeat-

    Key Metrics

    Valuation
    P/E Ratio-0.38EV/EBITDAN/A
    Price/FCFN/AFCF YieldN/A
    Profitability
    Profit Margin0.00%Operating Margin0.00%
    ROE-126.20%ROICN/A
    Financial Health
    Debt/Equity0.00xInterest CoverageN/A
    Current Ratio1.87xQuick Ratio1.87x
    Trading Statistics
    BetaN/AAvg Volume233.05K
    52-Week High$6.6552-Week Low$0.93

    Technical Indicators Dashboard

    Moving Averages

    SMA 10$1.07
    SMA 20$1.22
    SMA 50$1.58
    SMA 200$2.94
    EMA 10$1.10
    EMA 20$1.23
    EMA 50$1.59
    EMA 200$4.38

    MACD

    Line: -0.18Signal: -0.19Hist: 0.01

    ADX

    ADX: 35.8+DI: 12.0-DI: 31.5

    Aroon & PSAR

    Aroon Up8.0
    Aroon Down40.0
    PSAR$0.93

    Bollinger Bands

    Upper Band$1.61
    Lower Band$0.82
    %B Position6438%(Upper)
    Band Width0.31

    RSI (14-Day)

    Neutral
    33.7

    Momentum Oscillators

    Stoch %K17.1
    Stoch %D17.1
    Williams %R-77.8
    ROC (10d)-13.7%
    Momentum-0.17
    CCI (20d)-73.7
    MFI (14d)30.2

    Volatility Measures

    ATR (14d)$0.12(10.9%)
    StdDev (20d)0.20
    Hist Vol126.6%(High)

    Volume Flow

    VWAP$1.05
    OBV87.4M
    AD Line39.1M
    CMF (20d)-0.058

    Volume Metrics

    Avg Vol (20d)240.4K
    Vol Ratio0.3x(Low)
    VWMA (20d)$1.22

    Pivot Points

    R3$1.06
    R2$1.05
    R1$1.02
    Pivot Point$1.01
    S1$0.98
    S2$0.97
    S3$0.94

    Advanced Oscillators

    TSI-40.06
    Ultimate Osc54.7
    KST-355.10

    Financial Data

    QuarterJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023
    Total Revenue$0$0$-2,569,000$0$0$0$-2,135,000$0$0$2.13M$3.00M$4.87M
    Cost of Revenue$0$0N/A$0$0$0$-620,000$0$0$620,000$608,000$1.56M
    Gross Profit$0$0$-2,569,000$0$0$0$-1,515,000$0$0$1.51M$2.40M$3.31M
    Operating Expenses$6.63M$7.05M$6.99M$5.94M$8.87M$4.35M$-15,931,000$5.68M$7.18M$31.18M$35.00M$32.21M
    R&D$4.00M$4.91M$8.28M$3.60M$5.81M$3.11M$-9,640,000$4.79M$6.53M$21.96M$28.41M$25.45M
    SG&A$2.63M$2.14M$-1,297,000$2.33M$3.06M$1.24M$-3,890,000$881,000$650,000$6.82M$6.59M$6.75M
    Operating Income$-6,629,000$-7,051,000$-9,555,000$-5,938,000$-8,869,000$-4,354,000$14.42M$-5,676,000$-7,181,000$-29,666,000$-32,607,000$-28,898,000
    Interest Income$172,000$247,000$0$411,000$377,000$275,000$0$163,000$206,000$0$0$0
    Interest Expense$0$0$9.55M$0$0$5.22M$0$0$0$1.98M$604,000$0
    Income Before Tax$-6,457,000$-6,804,000$-19,107,000$-5,527,000$4.17M$-9,579,000$15.82M$-5,513,000$-6,975,000$-30,696,000$-30,610,000$-28,898,000
    Income Tax Expense$0$0$0$0$0$0$0$0$0$0$0$0
    Net Income$-6,457,000$-6,804,000$-11,948,000$-5,527,000$4.17M$-9,579,000$13.79M$-5,513,000$-6,975,000$-30,696,000$-32,337,000$-28,032,000
    EBITDA$-6,620,000$-7,062,000$-9,565,000$-5,939,000$3.74M$-9,901,000$14.44M$-5,652,000$-6,666,000$-29,182,000$-32,766,000$-28,942,000
    EBIT$-6,629,000$-7,051,000$-9,555,000$-5,938,000$3.79M$-9,854,000$14.42M$-5,676,000$-7,181,000$-28,714,000$-32,607,000$-28,898,000
    * Some calculated fields are derived from available data when not provided by source

    Related GNG Research

    No research available

    Be the first to write about TVRD

    TVRD Valuation and Fair Value

    P/E
    -0.4x
    P/B
    1.2x
    See GNG's fair value

    TVRD Profitability: Margins, ROIC and FCF

    Operating margin
    0.0%
    Net margin
    0.0%
    ROE
    -126.2%

    TVRD Competitors

    CompanyTicker
    Vyome Holdings, Inc.HIND
    Biofrontera IncBFRI
    Citius Pharmaceuticals IncCTXR
    Femasys IncFEMY
    SINTX Technologies IncSINT
    GT Biopharma IncGTBP
    Estrella Immunopharma Inc.ESLA
    Anebulo Pharmaceuticals IncANEB

    Sector: Healthcare

    TVRD Analyst Ratings

    Consensus
    Buy
    Analysts
    8
    Strong Buy
    2
    Buy
    4
    Hold
    1
    Sell
    0
    Strong Sell
    1

    TVRD Bull Case vs Bear Case

    Bull case

    • 75.0% of TVRD's analyst ratings are Buy or Strong Buy.

    Bear case

    • TVRD beat EPS estimates in 37.5% of its last 8 reported quarters.

    TVRD Earnings: Beat Rate and Next Report

    Beat rate
    3 of 8 quarters (37.5%)
    Average surprise
    -705.6%
    EPS estimate (fiscal period ending Sep 30, 2026)
    $-0.57
    Estimate revisions (30 days, fiscal period ending Sep 30, 2026)
    2 up, 0 down

    Frequently Asked Questions About TVRD

    Does TVRD pay dividends?

    Tvardi Therapeutics, Inc. (TVRD) does not currently pay a regular dividend.

    What is TVRD's market cap?

    Tvardi Therapeutics, Inc. (TVRD) has a market capitalization of $13.34M with a current stock price of $1.07.

    Related stocks

    Sector: Healthcare

    All stocks starting with T

    Get full access to GNG Research

    Create a free account to access portfolio tracking, advanced tools, and more.

    Create Free AccountLog In